Prolonged Remission in Metastatic Ano‐Rectal Malignant Melanoma With Single Agent Temozolomide
ABSTRACT Introduction With the use of immune checkpoint inhibitors (ICIs) and targeted therapies, the clinical outcomes of metastatic melanoma have drastically improved. The current scenario has reduced the use of chemotherapy as a first‐line treatment. We report an interesting case of a patient wit...
Saved in:
Main Authors: | Anusha Mruthyunjaya Swamy, Deepak Sundriyal, Mayank Kapoor, Mridul Khanna, Ravi Hari Phulware, Kranthi Kumar Jandrasupalli, Ujjawal Shriwastav, Amit Sehrawat |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-01-01
|
Series: | Cancer Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/cnr2.70121 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Associated adverse outcomes with tumor treating fields when combined to temozolomide versus temozolomide alone for the treatment of glioblastoma: a meta-analysis of randomized trials
by: Yuanyuan Chen, et al.
Published: (2025-02-01) -
Magnetic and pH sensitive nanocomposite microspheres for controlled temozolomide delivery in glioblastoma cells
by: Meysam Ahmadi, et al.
Published: (2024-12-01) -
E_N_T_R_O_P_Y: Monocentric analysis of rectal cancer radio-chemotherapy treatment in patients of young age
by: E. Meldolesi, et al.
Published: (2025-03-01) -
Complete Rectal Prolapse. Case presentation
by: José Antonio Feliu Rosa, et al.
Published: (2017-10-01) -
Mucinous rectal adenocarcinoma recurrence: A case report and literature review
by: Riya Sood, BS, et al.
Published: (2025-04-01)